2024 asa guidance glp-1 receptor agonists perioperative 2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations on the peri-procedural use of GLP-1/GIP Perioperative management of patients taking
Description
Two major ongoing trials are likely to change that, with potentially big implications for clinical practice.
Retatrutide 10mg: Triple Receptor Agonist Research Compound
Get compounded GLP-1 medication for seniors with Medicare for as low as $90.00 a month for a 4-week supply
Starting Jan.1, 2026, Pennsylvania will limit GLP1 weightloss drugs under Medicaid threatening access for thousands of lowincome patients.
The hidden costs of silencing hunger with GLP-1s like Wegovy and Ozempic.
Side Effects: As a GLP-1 therapy, common side effects are typically gastrointestinal, including nausea, vomiting, and diarrhea.
